{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T11:17:37Z","timestamp":1783077457782,"version":"3.54.6"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007747","name":"The University of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI139535"],"award-info":[{"award-number":["AI139535"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Biomaterials"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.celbio.2026.100490","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T15:03:02Z","timestamp":1779462182000},"page":"100490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune context governs stage-specific responses to depleting anti-PD-1 antibody in type 1 diabetes"],"prefix":"10.1016","author":[{"given":"Yujia","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren C.","family":"Naatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean R.","family":"Tantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tallulah","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7080-9804","authenticated-orcid":false,"given":"Mingnan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celbio.2026.100490_bib1","series-title":"The autoimmune diseases","first-page":"1209","article-title":"Treatment of autoimmune disease: established therapies","author":"Hahn","year":"2014"},{"key":"10.1016\/j.celbio.2026.100490_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-021-02778-6","article-title":"Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era","volume":"19","author":"Akil","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.celbio.2026.100490_bib3","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-021-01418-2","article-title":"100 years of insulin: celebrating the past, present and future of diabetes therapy","volume":"27","author":"Sims","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.celbio.2026.100490_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/dci21-0051","volume":"45","author":"Cefalu","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.celbio.2026.100490_bib5","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1126\/science.abh1654","article-title":"Immunotherapy: Building a bridge to a cure for type 1 diabetes","volume":"373","author":"Bluestone","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celbio.2026.100490_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-med-052814-023415","article-title":"Novel Agents for Relapsing Forms of Multiple Sclerosis","volume":"67","author":"Straus Farber","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.celbio.2026.100490_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102988","article-title":"Anti-CD20 antibody therapy and risk of infection in patients with demyelinating diseases","volume":"52","author":"Oksbjerg","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.celbio.2026.100490_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 Pathway in Tolerance and Autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.celbio.2026.100490_bib9","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/intimm\/8.5.765","article-title":"Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes","volume":"8","author":"Agata","year":"1996","journal-title":"Int. Immunol."},{"key":"10.1016\/j.celbio.2026.100490_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/EJE-19-0291","article-title":"Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review","volume":"181","author":"de Filette","year":"2019","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.celbio.2026.100490_bib11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41586-021-04248-x","article-title":"An autoimmune stem-like CD8 T cell population drives type 1 diabetes","volume":"602","author":"Gearty","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celbio.2026.100490_bib12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2337\/db16-0714","article-title":"Circulating CXCR5+PD-1+ICOS+ Follicular T Helper Cells Are Increased Close to the Diagnosis of Type 1 Diabetes in Children With Multiple Autoantibodies","volume":"66","author":"Viisanen","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.celbio.2026.100490_bib13","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s00125-019-4936-8","article-title":"Circulating CXCR5(-)PD-1(hi) peripheral T helper cells are associated with progression to type 1 diabetes","volume":"62","author":"Ekman","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.celbio.2026.100490_bib14","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.celrep.2016.10.042","article-title":"Programmed Death-1 Culls Peripheral Accumulation of High-Affinity Autoreactive CD4 T Cells to Protect against Autoimmunity","volume":"17","author":"Jiang","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.celbio.2026.100490_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.16","article-title":"Type 1 diabetes mellitus","volume":"3","author":"Katsarou","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.celbio.2026.100490_bib16","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/ni.2762","article-title":"A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application","volume":"14","author":"Okazaki","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celbio.2026.100490_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20022125","article-title":"The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice","volume":"198","author":"Ansari","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celbio.2026.100490_bib18","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1002\/eji.200324228","article-title":"Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses","volume":"33","author":"Liang","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celbio.2026.100490_bib19","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ni.1790","article-title":"Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal","volume":"10","author":"Fife","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celbio.2026.100490_bib20","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2337\/dc14-2349","article-title":"Precipitation of autoimmune diabetes with anti-PD-1 immunotherapy","volume":"38","author":"Hughes","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.celbio.2026.100490_bib21","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.2337\/dc15-1331","article-title":"Anti-PD1 Pembrolizumab Can Induce Exceptional Fulminant Type 1 Diabetes","volume":"38","author":"Gaudy","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.celbio.2026.100490_bib22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41551-019-0360-0","article-title":"Depletion of PD-1-positive cells ameliorates autoimmune disease","volume":"3","author":"Zhao","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.celbio.2026.100490_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4741","article-title":"Diphtheria toxin-derived, anti-PD-1 immunotoxin, a potent and practical tool to selectively deplete PD-1+ cells","volume":"32","author":"Zhang","year":"2023","journal-title":"Protein Sci."},{"key":"10.1016\/j.celbio.2026.100490_bib24","series-title":"The Autoimmune Diseases","first-page":"311","article-title":"Effector mechanisms in autoimmunity","author":"Laurence","year":"2014"},{"key":"10.1016\/j.celbio.2026.100490_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.645699","article-title":"Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases","volume":"12","author":"Zhai","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celbio.2026.100490_bib26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jconrel.2022.07.010","article-title":"Antibody-mediated depletion of programmed death 1-positive (PD-1+) cells","volume":"349","author":"Zhai","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.celbio.2026.100490_bib27","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.leukres.2014.06.014","article-title":"An improved recombinant Fab-immunotoxin targeting CD22 expressing malignancies","volume":"38","author":"Bera","year":"2014","journal-title":"Leuk. Res."},{"key":"10.1016\/j.celbio.2026.100490_bib28","first-page":"1098","article-title":"Extending human IgG half-life using structure-guided design","volume":"10","author":"Booth","year":"2018","journal-title":"mAbs"},{"key":"10.1016\/j.celbio.2026.100490_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28186438","article-title":"Therapeutic Antibodies in Medicine","volume":"28","author":"Sharma","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.celbio.2026.100490_bib30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41578-019-0112-5","article-title":"Engineering immunomodulatory biomaterials for type 1 diabetes","volume":"4","author":"Stabler","year":"2019","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.celbio.2026.100490_bib31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.actbio.2025.06.016","article-title":"Nano-based therapy for type 1 diabetes: from immuno-intervention to insulin delivery","volume":"201","author":"Pang","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.celbio.2026.100490_bib32","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00592-024-02245-w","article-title":"Use of teplizumab in children and adolescents at risk of type 1 diabetes: perspectives of parents and caregivers from an Italian Pediatric Diabetes Center","volume":"61","author":"Bombaci","year":"2024","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.celbio.2026.100490_bib33","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.2337\/dc23-0675","article-title":"Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves beta-Cell Function","volume":"46","author":"Herold","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.celbio.2026.100490_bib34","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.2337\/diabetes.49.12.1998","article-title":"Suppression and acceleration of autoimmune diabetes by neutralization of endogenous interleukin-12 in NOD mice","volume":"49","author":"Fujihira","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.celbio.2026.100490_bib35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jaut.2017.07.006","article-title":"Anti-IL-21 monoclonal antibody combined with liraglutide effectively reverses established hyperglycemia in mouse models of type 1 diabetes","volume":"84","author":"Ryd\u00e9n","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.celbio.2026.100490_bib36","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-020-1503-6","article-title":"Remission of autoimmune diabetes by anti-TCR combination therapies with anti-IL-17A or\/and anti-IL-6 in the IDDM rat model of type 1 diabetes","volume":"18","author":"J\u00f6rns","year":"2020","journal-title":"BMC Med."},{"key":"10.1016\/j.celbio.2026.100490_bib37","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.kint.2019.12.025","article-title":"Anti-CD20-mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives","volume":"97","author":"Crickx","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.celbio.2026.100490_bib38","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00125-018-4597-z","article-title":"B cell depletion reduces T cell activation in pancreatic islets in a murine autoimmune diabetes model","volume":"61","author":"Da Rosa","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.celbio.2026.100490_bib39","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.abh1657","article-title":"Strategies for durable \u03b2 cell replacement in type 1 diabetes","volume":"373","author":"Brusko","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celbio.2026.100490_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202300812","article-title":"Nanotargeted Delivery of Immune Therapeutics in Type 1 Diabetes","volume":"35","author":"Jung","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.celbio.2026.100490_bib41","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.actbio.2025.05.027","article-title":"Biomaterial-driven 3D scaffolds for immune cell expansion toward personalized immunotherapy","volume":"200","author":"Minopoli","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.celbio.2026.100490_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115179","article-title":"Immunoprotection of cellular transplants for autoimmune type 1 diabetes through local drug delivery","volume":"206","author":"Lansberry","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.celbio.2026.100490_bib43","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/dc15-1419","article-title":"Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association","volume":"38","author":"Insel","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.celbio.2026.100490_bib44","doi-asserted-by":"crossref","first-page":"E7776","DOI":"10.1073\/pnas.1707381114","article-title":"Imaging the emergence and natural progression of spontaneous autoimmune diabetes","volume":"114","author":"Mohan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celbio.2026.100490_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059701","article-title":"Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse","volume":"8","author":"Carrero","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.celbio.2026.100490_bib46","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20192362","article-title":"Single-cell RNA sequencing of murine islets shows high cellular complexity at all stages of autoimmune diabetes","volume":"217","author":"Zakharov","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celbio.2026.100490_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-45573-9","article-title":"TYK2 signaling promotes the development of autoreactive CD8+ cytotoxic T lymphocytes and type 1 diabetes","volume":"15","author":"Mine","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celbio.2026.100490_bib48","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jaut.2009.11.010","article-title":"Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment","volume":"34","author":"Van Belle","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.celbio.2026.100490_bib49","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1172\/JCI78492","article-title":"Anti-thymocyte globulin\/G-CSF treatment preserves beta cell function in patients with established type 1 diabetes","volume":"125","author":"Haller","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celbio.2026.100490_bib50","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.2337\/db16-0823","article-title":"Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes","volume":"65","author":"Haller","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.celbio.2026.100490_bib51","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1073\/pnas.1423769112","article-title":"Population dynamics of islet-infiltrating cells in autoimmune diabetes","volume":"112","author":"Magnuson","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celbio.2026.100490_bib52","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3109\/08916930903213993","article-title":"Islet lymphocyte subsets in male and female NOD mice are qualitatively similar but quantitatively distinct","volume":"42","author":"Young","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.celbio.2026.100490_bib53","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cmet.2018.11.014","article-title":"A Map of Human Type 1 Diabetes Progression by Imaging Mass Cytometry","volume":"29","author":"Damond","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.celbio.2026.100490_bib54","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cmet.2019.01.003","article-title":"Multiplexed In Situ Imaging Mass Cytometry Analysis of the Human Endocrine Pancreas and Immune System in Type 1 Diabetes","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.celbio.2026.100490_bib55","article-title":"Evolving Antibody Therapies for the Treatment of Type 1 Diabetes","volume":"11","author":"Ke","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celbio.2026.100490_bib56","doi-asserted-by":"crossref","first-page":"E10418","DOI":"10.1073\/pnas.1713543114","article-title":"Resident macrophages of pancreatic islets have a seminal role in the initiation of autoimmune diabetes of NOD mice","volume":"114","author":"Carrero","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celbio.2026.100490_bib57","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/imr.12430","article-title":"The role of islet antigen presenting cells and the presentation of insulin in the initiation of autoimmune diabetes in the NOD mouse","volume":"272","author":"Unanue","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.celbio.2026.100490_bib58","doi-asserted-by":"crossref","DOI":"10.1093\/immadv\/ltac011","article-title":"Targeting the high affinity receptor, Fc\u03b3RI, in autoimmune disease, neuropathy, and cancer","volume":"2","author":"Holtrop","year":"2022","journal-title":"Immunother. Adv."},{"key":"10.1016\/j.celbio.2026.100490_bib59","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41577-023-00985-4","article-title":"The immunology of type 1 diabetes","volume":"24","author":"Herold","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celbio.2026.100490_bib60","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1038\/s41596-021-00534-0","article-title":"Tutorial: guidelines for annotating single-cell transcriptomic maps using automated and manual methods","volume":"16","author":"Clarke","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celbio.2026.100490_bib61","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41587-021-01001-7","article-title":"Mapping single-cell data to reference atlases by transfer learning","volume":"40","author":"Lotfollahi","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celbio.2026.100490_bib62","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41586-018-0590-4","article-title":"Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris","volume":"562","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.celbio.2026.100490_bib63","article-title":"A diet enriched in omega-3 PUFA and inulin prevents type 1 diabetes by restoring gut barrier integrity and immune homeostasis in NOD mice","volume":"13","author":"Lo Conte","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celbio.2026.100490_bib64","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1253\/circj.CJ-14-0644","article-title":"Regulatory\/effector T-cell ratio is reduced in coronary artery disease","volume":"78","author":"Emoto","year":"2014","journal-title":"Circ. J."},{"key":"10.1016\/j.celbio.2026.100490_bib65","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12864-020-07358-4","article-title":"Systematic comparison of high-throughput single-cell RNA-seq methods for immune cell profiling","volume":"22","author":"Yamawaki","year":"2021","journal-title":"BMC Genomics"},{"key":"10.1016\/j.celbio.2026.100490_bib66","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-018-2226-y","article-title":"DrImpute: imputing dropout events in single cell RNA sequencing data","volume":"19","author":"Gong","year":"2018","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.celbio.2026.100490_bib67","article-title":"TNF-alpha and IFN-gamma gene variation and genetic susceptibility to type 1 diabetes and its microangiopathic complications","volume":"13","author":"Bazzaz","year":"2014","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.celbio.2026.100490_bib68","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41574-020-0355-7","article-title":"Pancreatic \u03b2-cells in type 1 and type 2 diabetes mellitus: different pathways to failure","volume":"16","author":"Eizirik","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.celbio.2026.100490_bib69","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s00125-024-06106-7","article-title":"Interferons are key cytokines acting on pancreatic islets in type 1 diabetes","volume":"67","author":"Coomans de Brach\u00e8ne","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.celbio.2026.100490_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/v16101623","article-title":"Activation-Induced Marker Assay to Identify and Isolate HCV-Specific T Cells for Single-Cell RNA-Seq Analysis","volume":"16","author":"Eisa","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.celbio.2026.100490_bib71","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s12276-023-00995-1","article-title":"Steady-state memory-phenotype conventional CD4+ T cells exacerbate autoimmune neuroinflammation in a bystander manner via the Bhlhe40\/GM-CSF axis","volume":"55","author":"Cho","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.celbio.2026.100490_bib72","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.celbio.2026.100490_bib73","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1210\/jc.2017-00569","article-title":"Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives","volume":"102","author":"Bosi","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.celbio.2026.100490_bib74","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221920","article-title":"Single-cell profiling reveals unique features of diabetogenic T cells in anti-PD-1-induced type 1 diabetes mice","volume":"220","author":"Collier","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celbio.2026.100490_bib75","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/cei.12697","article-title":"Anti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophages","volume":"183","author":"Church","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.celbio.2026.100490_bib76","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.4049\/jimmunol.180.5.2863","article-title":"B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions","volume":"180","author":"Xiu","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.celbio.2026.100490_bib77","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.immuni.2024.04.017","article-title":"CXCL16-dependent scavenging of oxidized lipids by islet macrophages promotes differentiation of pathogenic CD8+ T cells in diabetic autoimmunity","volume":"57","author":"Srivastava","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.celbio.2026.100490_bib78","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1084\/jem.20170074","article-title":"The islet-resident macrophage is in an inflammatory state and senses microbial products in blood","volume":"214","author":"Ferris","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celbio.2026.100490_bib79","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1007\/s00125-018-4592-4","article-title":"The resident macrophages in murine pancreatic islets are constantly probing their local environment, capturing beta cell granules and blood particles","volume":"61","author":"Zinselmeyer","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.celbio.2026.100490_bib80","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/s41586-025-09560-4","article-title":"Efferocytic remodelling of pancreatic islet macrophages by limited \u03b2-cell death","volume":"647","author":"Zakharov","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.celbio.2026.100490_bib81","doi-asserted-by":"crossref","first-page":"31319","DOI":"10.1073\/pnas.2019743117","article-title":"Cytocidal macrophages in symbiosis with CD4 and CD8 T cells cause acute diabetes following checkpoint blockade of PD-1 in NOD mice","volume":"117","author":"Hu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celbio.2026.100490_bib82","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/ni.3659","article-title":"Postprandial macrophage-derived IL-1\u03b2 stimulates insulin, and both synergistically promote glucose disposal and inflammation","volume":"18","author":"Dror","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celbio.2026.100490_bib83","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adh0085","article-title":"Targeted depletion of PD-1\u2013expressing cells induces immune tolerance through peripheral clonal deletion","volume":"9","author":"Cui","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celbio.2026.100490_bib84","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jaci.2020.03.036","article-title":"Targeting inducible costimulator expressed on CXCR5+PD-1+ TH cells suppresses the progression of pemphigus vulgaris","volume":"146","author":"Kim","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.celbio.2026.100490_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100144","article-title":"Preparing Highly Viable Single-Cell Suspensions from Mouse Pancreatic Islets for Single-Cell RNA Sequencing","volume":"1","author":"Lee","year":"2020","journal-title":"Star Protoc."},{"key":"10.1016\/j.celbio.2026.100490_bib86","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s41588-022-01118-8","article-title":"Systematic identification of cell-fate regulatory programs using a single-cell atlas of mouse development","volume":"54","author":"Fei","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celbio.2026.100490_bib87","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/nar\/gkac633","article-title":"Construction of a cross-species cell landscape at single-cell level","volume":"51","author":"Wang","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celbio.2026.100490_bib88","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1261\/rna.078965.121","article-title":"Review of single-cell RNA-seq data clustering for cell-type identification and characterization","volume":"29","author":"Zhang","year":"2023","journal-title":"RNA"},{"key":"10.1016\/j.celbio.2026.100490_bib89","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celbio.2026.100490_bib90","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/s41592-023-02014-7","article-title":"Extending support for mouse data in the Molecular Signatures Database (MSigDB)","volume":"20","author":"Castanza","year":"2023","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celbio.2026.100490_bib91","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s42255-022-00531-x","article-title":"Single-cell multi-omics analysis of human pancreatic islets reveals novel cellular states in type 1 diabetes","volume":"4","author":"Fasolino","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.celbio.2026.100490_bib92","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s42255-023-00806-x","article-title":"Single-cell expression profiling of islets generated by the Human Pancreas Analysis Program","volume":"5","author":"Patil","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.celbio.2026.100490_bib93","doi-asserted-by":"crossref","first-page":"D886","DOI":"10.1093\/nar\/gkae1142","article-title":"CZ CELLxGENE Discover: a single-cell data platform for scalable exploration, analysis and modeling of aggregated data","volume":"53","author":"Abdulla","year":"2025","journal-title":"Nucleic Acids Res."}],"container-title":["Cell Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050562326001467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050562326001467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:24:00Z","timestamp":1783074240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050562326001467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":93,"alternative-id":["S3050562326001467"],"URL":"https:\/\/doi.org\/10.1016\/j.celbio.2026.100490","relation":{},"ISSN":["3050-5623"],"issn-type":[{"value":"3050-5623","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune context governs stage-specific responses to depleting anti-PD-1 antibody in type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Cell Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celbio.2026.100490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100490"}}